FID-007
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for FID-007, covering 2025-08-12 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]